Conference abstract · 25 Mar 2019
Byline
H. Shirwan
Articles whose byline reads H. Shirwan, printed as Haval Shirwan. Different authors can share a byline.
- Articles
- 27
- Latest year
- 2019
Articles
Newest first. Showing 1–25 of 27 articles.
Conference abstract · 25 Mar 2019
PLG scaff olds engineered with an immunomodulatory molecule as an effective means of establishing localized tolerance to pancreatic islet grafts
Conference abstract · 19 Mar 2018
Induction of tolerance to allogeneic islet grafts using an immunomodulatory biomaterial
Conference abstract · 19 Mar 2018
Pancreatic islets engineered with a chimeric PD-L1 protein overcome rejection in allogeneic recipients
Conference abstract · 19 Mar 2018
Pancreatic islets engineered with a chimeric PD-L1 protein overcome rejection in allogeneic recipients
Conference abstract · 19 Mar 2018
Induction of tolerance to allogeneic islet grafts using an immunomodulatory biomaterial
Conference abstract · 20 Mar 2017
SA-4-1BBL as an adjuvant platform for the development of vaccines
Conference abstract · 20 Mar 2017
Targeted deletion of pathogenic T effector cells as a robust means of allograft tolerance
Conference abstract · 20 Mar 2017
SA-4-1BBL as an adjuvant platform for the development of vaccines
Conference abstract · 20 Mar 2017
Targeted deletion of pathogenic T effector cells as a robust means of allograft tolerance
Conference abstract · 29 Feb 2016
Specific targeting of pathogenic T-cells for the induction of tolerance to pancreatic islet grafts for the treatment of type-1 diabetes
Conference abstract · 29 Feb 2016
Mechanistic basis of allotolerance induced by SA-FasL-engineered pancreatic islets
Conference abstract · 29 Feb 2016
Mechanistic basis of allotolerance induced by SA-FasL-engineered pancreatic islets
Conference abstract · 29 Feb 2016
Specific targeting of pathogenic T-cells for the induction of tolerance to pancreatic islet grafts for the treatment of type-1 diabetes
Conference abstract · 23 Mar 2015
Apoptosis as an effective means of inducing tolerance to pancreatic islets for the treatment of type 1 diabetes
Conference abstract · 23 Mar 2015
ProtEx™ technology as an effective means of engineering bone marrow cells with immunoregulatory molecules for the establishment of mixed hematopoietic chimerism
Conference abstract · 2015
Apoptosis as an effective means of inducing tolerance to pancreatic islets for the treatment of type 1 diabetes
Conference abstract · 2015
Apoptosis as an effective means of inducing tolerance to pancreatic islets for the treatment of type 1 diabetes
Conference abstract · 2015
ProtEx™ technology as an effective means of engineering bone marrow cells with immunoregulatory molecules for the establishment of mixed hematopoietic chimerism
Conference abstract · 20 Nov 2013
Engineering cells and tissues with exogenous immunomodulatory proteins for the induction of tolerance to auto and alloantigens
Conference abstract · 20 Nov 2013
Systemic immunomodulation with SA-FasL-engineered donor splenocytes as an effective means of inducing tolerance to cardiac allografts
Conference abstract · 12 Nov 2012
The direct display of immunological ligands on allogeneic hematopoietic stem cells and tissues as an effective means of inducing tolerance
Editorial · 2012
The Promise of PD-1 Signaling Pathway for Cancer Immunotherapy
Conference abstract
Exploiting synergy between TNFR and TLR4 signaling for the development of adjuvant systems
Conference abstract

